Heart failure biomarkers (Q38100647)

28 August 2017

Heart failure biomarkers (English)

1 reference

28 August 2017

0 references

Rajiv Choudhary

1

1 reference

28 August 2017

Navaid Iqbal

2

1 reference

28 August 2017

Fatima Khusro

3

1 reference

28 August 2017

Erin Higginbotham

4

1 reference

28 August 2017

Erik Green

5

1 reference

28 August 2017

Alan Maisel

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

20 April 2013

1 reference

Journal of Cardiovascular Translational Research

28 August 2017

1 reference

28 August 2017

6

1 reference

28 August 2017

4

1 reference

28 August 2017

471-484

1 reference

https://scigraph.springernature.com/pub.10.1007/s12265-013-9465-0

28 August 2017

0 references

cites work

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

A new natriuretic peptide in porcine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Use of natriuretic peptides to guide and monitor heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Pro-B-type natriuretic peptide levels in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Adrenomedullin: potential in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Cardiac troponin-I: a biochemical marker for cardiac cell necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Early diagnosis of myocardial infarction with sensitive cardiac troponin assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

The association between pneumococcal pneumonia and acute cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Co-peptin: Role as a novel biomarker in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Short-term mortality risk in emergency department acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-013-9465-0

B-type natriuretic peptide (BNP) or N-terminal-proBNP for the diagnosis of heart failure: which peptide is the better choice?

21 January 2018

1 reference

12 December 2020

Adrenomedullin--what do we know 10 years since its discovery?

1 reference

12 December 2020

N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study

1 reference

12 December 2020

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

1 reference

12 December 2020

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

1 reference

12 December 2020

Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure

1 reference

12 December 2020

Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.

1 reference

12 December 2020

MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation

1 reference

12 December 2020

Benchmarks for the assessment of novel cardiovascular biomarkers

1 reference

12 December 2020

Circulating cardiac troponin I in severe congestive heart failure

1 reference

12 December 2020

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

1 reference

12 December 2020

High serum procalcitonin concentrations in patients with sepsis and infection

1 reference

12 December 2020

10.1007/S12265-013-9465-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference